NEW YORK, NEW YORK (September 10, 2003) — Bristol-Myers Squibb Company (NYSE: BMY) and QDose, a joint venture between MicroDose Technologies, Inc. and Quadrant Drug Delivery, Ltd., today announced that the companies have entered into a licensing agreement for the QDose inhaled insulin product.